DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Vision - The vision of the PRP is to increase the understanding of PD and to develop treatments towards a cure

Parkinson's Program Cover Image
»  Click on Image to View Program Booklet

Parkinson’s disease (PD) is a degenerative movement disorder of the central nervous system resulting from a loss of neurons in a region of the brain called the substantia nigra. These neurons produce dopamine, a neurotransmitter important for motor control; however, as PD progresses, the death of dopaminergic neurons results in reduced dopamine levels and impairment of motor control.

For FY22, Congress transitioned the Neurotoxin Exposure Treatment Parkinson’s (NETP) program to the Parkinson’s Research Program (PRP) and broadened the research from neurotoxin exposure treatment PD research to all types of PD research. The PRP challenges the scientific community to develop the most impactful research that will advance the understanding of the disease, with the ultimate goal of ending PD.

For information on toxic exposures research, please go to the Toxic Exposures Research Program at CDMRP.




Congressional Appropriations

Congressional Appropriations

  • $16 million
    FY22

Programmatic Panels

Programmatic
Panels


Related Videos

Dr. Angus Nairn Video

Yale University School of Medicine
Proteomic Methods for Analyzing Protein in Dopaminergic Neurons

Dr. Andrew Singleton Video

National Institute on Aging
Whole-Genome Sequencing in Parkinson’s
Disease

Dr. Kenneth Marek Video

Institute for Neurodegenerative Disorders
Evaluating the Natural History of Prodromal PD in the PARS Cohort

Dr. Caroline Tanner

University of California, San Francisco
Persistent Organic Pollutants and Parkinson’s disease in Native Populations of Hawaii and Alaska

Dr. Paul Greengard

Rockefeller University
New P11 Biomarker Predicts Clinical Effectiveness of Antidepressant Drugs

Dr. Howard J. Federoff

University of California, Irvine
PGC-1α Therapy for Parkinson Neurodegeneration

news_icon News & Highlights

Vision

The vision of the PRP is to increase the understanding of PD and to develop treatments towards a cure

Mission

The mission of the PRP is to support high impact Parkinson’s research to benefit both the military and the American public.

Last updated Friday, April 29, 2022